Taiwan · Delayed Price · Currency is TWD UniPharma Statistics
Total Valuation
UniPharma has a market cap or net worth of TWD 410.04 million. The enterprise value is 314.77 million.
| Market Cap | 410.04M |
| Enterprise Value | 314.77M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UniPharma has 35.50 million shares outstanding.
| Current Share Class | 35.50M |
| Shares Outstanding | 35.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.28% |
| Owned by Institutions (%) | n/a |
| Float | 27.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.89 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.85 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.35 |
| Interest Coverage | -293.55 |
Financial Efficiency
Return on equity (ROE) is -17.90% and return on invested capital (ROIC) is -41.86%.
| Return on Equity (ROE) | -17.90% |
| Return on Assets (ROA) | -10.86% |
| Return on Invested Capital (ROIC) | -41.86% |
| Return on Capital Employed (ROCE) | -22.53% |
| Weighted Average Cost of Capital (WACC) | 2.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 34 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.41% in the last 52 weeks. The beta is -0.23, so UniPharma's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -9.41% |
| 50-Day Moving Average | 11.35 |
| 200-Day Moving Average | 12.24 |
| Relative Strength Index (RSI) | 51.50 |
| Average Volume (20 Days) | 40,861 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UniPharma had revenue of TWD 83.87 million and -40.10 million in losses. Loss per share was -1.13.
| Revenue | 83.87M |
| Gross Profit | 42.65M |
| Operating Income | -45.79M |
| Pretax Income | -40.10M |
| Net Income | -40.10M |
| EBITDA | -41.44M |
| EBIT | -45.79M |
| Loss Per Share | -1.13 |
Balance Sheet
The company has 107.59 million in cash and 12.32 million in debt, with a net cash position of 95.27 million or 2.68 per share.
| Cash & Cash Equivalents | 107.59M |
| Total Debt | 12.32M |
| Net Cash | 95.27M |
| Net Cash Per Share | 2.68 |
| Equity (Book Value) | 196.80M |
| Book Value Per Share | 5.56 |
| Working Capital | 123.18M |
Cash Flow
In the last 12 months, operating cash flow was -33.83 million and capital expenditures -1.16 million, giving a free cash flow of -34.99 million.
| Operating Cash Flow | -33.83M |
| Capital Expenditures | -1.16M |
| Depreciation & Amortization | 3.23M |
| Net Borrowing | -3.68M |
| Free Cash Flow | -34.99M |
| FCF Per Share | -0.99 |
Margins
Gross margin is 50.86%, with operating and profit margins of -54.60% and -47.80%.
| Gross Margin | 50.86% |
| Operating Margin | -54.60% |
| Pretax Margin | -47.80% |
| Profit Margin | -47.80% |
| EBITDA Margin | -49.41% |
| EBIT Margin | -54.60% |
| FCF Margin | n/a |
Dividends & Yields
UniPharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.78% |
| FCF Yield | -8.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |